Health Condition 1: E785- Hyperlipidemia, unspecified
Conditions
Interventions
Intervention1: Allium sativum in decimal scale:
Oral route of administration
30 Pill size globule 5 medicated globules orally once daily for fifteen days and then 5 globules of placebo once daily up
Sponsors
Bakson Homoeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Pre-diagnosed and confirmed cases of dyslipidemia Participants with lipid levels within the following ranges based on NCEP ATP III guidelines Total Cholesterol between 200 and 300 mg/dL LDL Cholesterol between 130 and 189 mg/dL Triglycerides between 150 and 400 mg/dL and HDL Cholesterol less than 40 mg/dL Participants who willing participate will provide written consent and comply with Allium sativum treatment and lipid monitoring Participants with BMI in the following ranges Normal 18.5 to 24.9 kg/m? Overweight 25.0 to29.9 kg/m? and Class I Obese 30.0 to 34.9 kg/m?
Exclusion criteria
Exclusion criteria: Individuals with uncontrolled hypertension or poorly managed diabetes Participants with Class II obesity with BMI 35.0 to 39.9 kg/m? and Class III with BMI more than equal to 40.0 kg/m? Those with severe systemic illnesses or immunocompromised states Individuals with severe psychiatric disorders that may impair consent or adherence Pregnant or lactating women Fasting triglyceride levels more than 400 mg/dL Known allergy or hypersensitivity to Allium sativum that is garlic Participants currently using statins blood thinners or steroidal medications Active alcohol or tobacco users Participants taking any form of steroidal treatment in last 3 months Participants having vitiligo asthma atopic dermatitis psoriasis systemic lupus erythematous and any localized traumatic history
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare Allium sativum in centesimal and decimal potency in dyslipidemia via changes in lipid profile rangesTimepoint: 16 months study 6 months enrollment 6 months follow up 4 month data analysis and report writing | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: Not applicable | — |
Countries
India
Contacts
Public ContactDr Meenakshi Ambwani
Bakson Homoeopathic Medical College and Hospital
Outcome results
None listed